Skip to main content
OpenTrials

Clinical trial condition

Myasthenia Gravis, Generalized

Explore clinical trials studying Myasthenia Gravis, Generalized. Study availability and eligibility vary by location and protocol.

25 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Myasthenia Gravis, Generalized trial results

Completed

Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis

NCT04115293

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Site 41: Diagnostic and Medical Clinic Mobile, Alabama, United States
  • Site 116: Neuromuscular Clinic and Research Center Phoenix, Arizona, United States
  • Site 4: University of Southern California Los Angeles, California, United States
  • Site 31: University of California Irvine Orange, California, United States
View all 77 locations
View Trial Details
Completed

Study of Telitacicept in Generalized Myasthenia Gravis

NCT05737160

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +19 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Xuanwu Hospital of Capital Medical University Beijing, Beijing Municipality, China
View all 51 locations
View Trial Details
Completed

A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG)

NCT03759366

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +12 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Columbia, Missouri, United States
View Trial Details
Completed

Safety,Tolerability,Pharmacokinetics and Efficacy of CFZ533 in Moderate to Severe Myasthenia Gravis

NCT02565576

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Québec, Quebec, Canada
  • Novartis Investigative Site Aarhus, Denmark
  • Novartis Investigative Site Copenhagen, Denmark
View all 15 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis

NCT02473952

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Phoenix Neurological Associates, Ltd. Phoenix, Arizona, United States
  • University of California-Irvine Orange, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • University of Florida Health Science Center Jacksonville, Florida, United States
View all 40 locations
View Trial Details

Related conditions